Company
Headquarters: Bad Neustadt an der Saale, Germany
Employees: 18,159
CEO: Dr. Christian Hoftberger
€846.1 Million
EUR as of July 1, 2024
US$908.8 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
RHàN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. As of December 31, 2019, it operated 8 hospitals and 5,312 beds/places at 5 medical sites. The company is headquartered in Bad Neustadt an der Saale, Germany.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
RHÖN-KLINIKUM Aktiengesellschaft has the following listings and related stock indices.
Stock: FSX: RHKU wb_incandescent